Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)
Related Experiment Video
Updated: Oct 30, 2026

Generation of Mice Derived from Induced Pluripotent Stem Cells
Published on: November 29, 2012
J Y Chang1, D M Monroe, J A Oliver
1Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, 27599-7035, USA. jychang@med.unc.edu
Abstract:
Tissue factor pathway inhibitor (TFPI) acts to regulate the initiation of coagulation by first inhibiting factor Xa. The complex of factor Xa/TFPI then inhibits the factor VIIa/tissue factor complex. The cDNA sequences of TFPI from several different species have been previously reported. A high level of similarity is present among TFPIs at the molecular level (DNA and protein sequences) as well as in biochemical function (inhibition of factor Xa, VIIa/tissue factor). In this report, we used a PCR-based screening method to clone cDNA for full length TFPI from a mouse macrophage cDNA library. Both cDNA and predicted protein sequences show significant homology to the other reported TFPI sequences, especially to that of rat. Mouse TFPI has a signal peptide of 28 amino acid residues followed by the mature protein (in which the signal peptide is removed) which has 278 amino acid residues. Mouse TFPI, like that of other species, consists of three tandem Kunitz type domains. Recombinant mouse TFPI was expressed in the human kidney cell line 293 and purified for functional assays. When using human clotting factors to investigate the inhibition spectrum of mouse TFPI, it was shown that, in addition to human factor Xa, mouse TFPI inhibits human factors VIIa, IXa, as well as factor XIa. Cloning and expression of the mouse TFPI gene will offer useful information and material for coagulation studies performed in a mouse model system.
Insights
Researchers cloned and expressed mouse tissue factor pathway inhibitor (TFPI), a key regulator of blood coagulation. This mouse TFPI inhibits multiple human clotting factors, providing valuable tools for coagulation research in mouse models.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Tissue factor pathway inhibitor (TFPI) is a critical regulator of blood coagulation initiation.
- TFPI primarily inhibits factor Xa and the factor VIIa/tissue factor complex.
- High molecular and functional similarity exists across species for TFPI.
Purpose of the Study:
- To clone the full-length cDNA for mouse TFPI.
- To express and functionally characterize recombinant mouse TFPI.
- To provide resources for mouse model coagulation studies.
Main Methods:
- PCR-based screening of a mouse macrophage cDNA library.
- DNA and protein sequence analysis.
- Recombinant protein expression in human kidney 293 cells and purification.
- Functional assays using human clotting factors.
Main Results:
- Full-length mouse TFPI cDNA was successfully cloned.
- Mouse TFPI shares significant sequence homology with other species, particularly rat TFPI.
- Recombinant mouse TFPI demonstrated inhibitory activity against human factors Xa, VIIa, IXa, and XIa.
Conclusions:
- The cloned and expressed mouse TFPI is homologous to other species' TFPIs.
- Mouse TFPI exhibits a broad inhibition spectrum against human coagulation factors.
- This study provides essential tools and data for investigating coagulation in mouse models.
